(Q39067495)

8 September 2017

PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer (English)

1 reference

8 September 2017

1 reference

B-X Yan

1

1 reference

8 September 2017

J-X Ma

2

1 reference

8 September 2017

J Zhang

3

1 reference

8 September 2017

Y Guo

4

1 reference

8 September 2017

H Riedel

5

1 reference

8 September 2017

M D Mueller

6

1 reference

8 September 2017

S C Remick

7

1 reference

8 September 2017

J J Yu

8

1 reference

8 September 2017

language of work or name

English

0 references

publication date

4 November 2013

1 reference

8 September 2017

1 reference

8 September 2017

33

1 reference

8 September 2017

45

1 reference

8 September 2017

5288-5294

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.466

8 September 2017

0 references

cites work

Molecular mechanisms of drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Resistance mechanisms to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

RPN2 gene confers docetaxel resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Overcoming drug resistance by regulating nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

An overview of cancer multidrug resistance: a still unsolved problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Three predominant proteins secreted by the human prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Prostatic secretory protein (PSP94) expression in human female reproductive tissues, breast and in endometrial cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

let-7 microRNAs in development, stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

The role of let-7 in cell differentiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Selective blockade of microRNA processing by Lin28

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Lin28 promotes transformation and is associated with advanced human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Molecular mechanisms of resistance and toxicity associated with platinating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Characterization of a human ovarian carcinoma cell line: UCI 101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

LIN28B confers radio-resistance through the posttranscriptional control of KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

Three predominant prostatic proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.466

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2013.466

1 reference

8 September 2017

1 reference